ArticleFrontiers in pharmacology2026

Phillygenin suppresses hepatocellular carcinoma progression by modulating the TNF signaling pathway and TCA cycle metabolism.

Jiao Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.